Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Blood Advances
|
May 12, 2019
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
Lova Sun, Johnathan Mack, Ang Li, et al.
Journal of Biomedical Nanotechnology
|
June 17, 2016
Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme
Lova Sun, Daniel Y Joh, Ajlan Al-Zaki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs
Vivek Narayan, Tao Liu, Yunjie Song, et al.
The Laryngoscope
|
May 2, 2023
Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy
Joseph S Lu, Austin C Cao, David Shimunov, et al.
Clinical Lung Cancer
|
January 11, 2023
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer
Kristine N Kim, Jonathan Heintz, Nikhil Yegya-Raman, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
June 23, 2022
Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma
Lova Sun, Robert Brody, Danielle Candelieri, et al.
Clinical Lung Cancer
|
January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
Omar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JTO Clinical and Research Reports
|
August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC
Omar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
Plos One
|
May 3, 2013
Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization
Daniel Y Joh, Lova Sun, Melissa Stangl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
Lova Sun, Sanjna Surya, Anh N Le, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Blood Advances
|
May 12, 2019
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
Lova Sun, Johnathan Mack, Ang Li, et al.
Journal of Biomedical Nanotechnology
|
June 17, 2016
Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme
Lova Sun, Daniel Y Joh, Ajlan Al-Zaki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs
Vivek Narayan, Tao Liu, Yunjie Song, et al.
The Laryngoscope
|
May 2, 2023
Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy
Joseph S Lu, Austin C Cao, David Shimunov, et al.
Clinical Lung Cancer
|
January 11, 2023
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer
Kristine N Kim, Jonathan Heintz, Nikhil Yegya-Raman, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
June 23, 2022
Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma
Lova Sun, Robert Brody, Danielle Candelieri, et al.
Clinical Lung Cancer
|
January 1, 2025
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
Omar Elghawy, Adam Barsouk, Lauren Reed-Guy, et al.
JTO Clinical and Research Reports
|
August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC
Omar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
Plos One
|
May 3, 2013
Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization
Daniel Y Joh, Lova Sun, Melissa Stangl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
Lova Sun, Sanjna Surya, Anh N Le, et al.
Page
of 9